Black Men And Prostate Cancer: A Clue
Feb-25-2007
Compared with white men, African American men are 50 percent more likely to develop prostate cancer, and twice as likely to die from it. They also tend to develop it at younger ages. Like other cancer genetics researchers, Matthew Freedman figured at least part of the explanation for this disparity must lie in the DNA. After all, defective genes that increased breast-cancer risk had been isolated in women, so it was reasonable to assume the equivalent was at work in prostate cancer. It turns out, Freedman said last week, that genetic predisposition to prostate cancer is much more complicated. Speaking at a Wistar Institute symposium on African American men and prostate cancer, Freedman explained how he and his colleagues at Dana Fa...
OHSU Cancer Institute Researcher Identifies Protein Marker For Prostate Cancer Survival
Feb-25-2007
PORTLAND -- An Oregon Health & Science University Cancer Institute researcher has identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation. "This could mean that a simple blood test that is already available could help patients and doctors make better decisions as they become more informed about what to expect from the prostate cancer they are facing," said Tomasz Beer, M.D., director of the Prostate Cancer Research at the OHSU Cancer Institute, associate professor of medicine, (hematology/medical oncology) OHSU School of Medicine. Bee...
New Clinical Data For PROSTASCINT(R) And QUADRAMET(R) In Prostate Cancer Presented
Feb-25-2007
ORLANDO -- Cytogen Corporation today reported that clinical investigators from leading cancer research centers presented data from recent and ongoing clinical trials of both PROSTASCINT(R) (capromab pendetide) and QUADRAMET(R) (samarium Sm-153 lexidronam injection) in prostate cancer at the 2007 Prostate Cancer Symposium, multidisciplinary meeting co-sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Therapeutic Radiology and Oncology (ASTRO), and the Society of Urologic Oncology (SUO) held February 22-24, 2007 in Orlando, Florida. The six PROSTASCINT-related presentations were highlighted by two studies that evaluated the outcomes of prostate cancer patients based on the image findings...
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +1986 new citations
Feb-27-2007
1986 new PubMed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results:
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT]))
These PubMed results were generated on 2007/02/27
PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.
Prostate Cancer Therapy May Increase Risk Of Death From Heart Disease In Older Men
Feb-28-2007
Main Category: Prostate / Prostate Cancer News Article Date: 28 Feb 2007 - 8:00 PST Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from ...
Prostate Cancer Free
Feb-26-2007
TRANSCRIPT FRANK FOWLER SPENT MOST OF HIS LIFE IN THE NAVY. WHEN HE WAS DIAGNOSED WITH PROSTATE CANCER, HE VOWED, LIKE WITH ANY OTHER ENEMY, THAT HE'D FIGHT BACK AND WIN.
Oral Satraplatin as Second-Line Therapy in Advanced Prostate Cancer
Feb-27-2007
The investigation drug satraplatin significantly reduced the risk for disease progression in a phase 3 trial in patients with advanced prostate cancer no longer responding to hormonal therapy or chemotherapy.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
Tests may spot most deadly prostate cancers
Feb-26-2007
Physicians may soon be able to identify which men have a more deadly form of prostate cancer, U.S. researchers report.
Men's Health: Most With Low-Risk Prostate Cancer Choose Treatment
Feb-25-2007
Men with prostate cancer in its earliest stage have a tough choice: Treat the disease, even though it may never progress to be a health threat, or wait and monitor it for signs that it's spreading. Despite a low risk of spread and the potential unpleasantness of surgery, radiation therapy, or chemo, a new study finds that only a small fraction of eligible men opt for so-called watchful waiting.
Toremifene May Counter Adverse Effects of Hormone Treatment for Prostate Cancer
Feb-27-2007
Emerging data from an ongoing trial in prostate cancer suggest that toremifene may counter the adverse effects that androgen deprivation therapy has on bone and lipid profiles.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
Green tea and COX-2 inhibitors combine to slow growth of prostate cancer
Feb-28-2007
Drinking a nice warm cup of green tea has long been touted for its healthful benefits, both real and anecdotal. But now researchers have found that a component of green tea, combined with low doses of a COX-2 inhibitor, could slow the spread of human prostate cancer.
Scientists tout new prostate cancer test
(AP)
Feb-27-2007
AP - Oregon scientists say a simple test can identify men at high risk of life-threatening prostate cancer even after a biopsy finds no signs of it. The key, researchers say, is "PSA density," which compares the size of a man's prostate with his levels of a cancer-related protein called prostate-specific antigen.
C-Reactive Protein Could Predict Prognosis in Advanced Prostate Cancer
Feb-26-2007
A readily available blood test for CRP could be a useful for predicting prognosis in advanced prostate cancer.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
Feb. 25, 2007
Feb-26-2007
One of the most common treatments for prostate cancer may give older patients an increased risk of death from heart disease.
Breast cancer drug could help prostate patients
Feb-25-2007
A breast cancer drug could help men with prostate cancer avoid some dangerous side effects of treatment, a study shows.